Late Detection of Atrial Fibrillation after Stroke: Implications for the Secondary Prevention

被引:2
|
作者
Tanislav, Christian [1 ]
Kostev, Karel [2 ]
机构
[1] Diakonie Hosp Jung Stilling Siegen, Dept Geriatr & Neurol, Wichernstr 40, DE-57074 Siegen, Germany
[2] IQVIA, Epidemiol, Frankfurt, Germany
关键词
Atrial fibrillation; Stroke; Embolic stroke; Oral anticoagulation; Anticoagulants; CRYPTOGENIC STROKE; ISCHEMIC-STROKE; WARFARIN; DABIGATRAN; DISEASE; YOUNG; SCORE;
D O I
10.1159/000503562
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: This study is aimed at investigating the incidence of atrial fibrillation (AF) within 5 years after an acute cerebrovascular event in AF-naive patients and its relevance for secondary prevention. Methods: The current case-control study sample included patients who had received an initial ischemic stroke diagnosis documented in the Disease Analyzer database (IQVIA), which compiles data such as risk factors, drug prescriptions, and diagnoses obtained from 1,262 general practices in Germany. Results: After the selection procedure, the stroke and non-stroke groups each included 22,774 patients. In both groups, the mean age of the population was 68.0 years (SD +/- 12 years), and the proportion of male participants was 51.1%. Within 5 years of follow-up, we calculated a higher probability for detecting AF in stroke patients than in controls (hazard ratio 4.95; 95% CI 1.93-2.09, p < 0.001). In the stroke group, AF was detected in 2,369 individuals (10.4%), whereas AF was only evident in 1,101 patients (4.8%) in the non-stroke group. In 1,741 (73.5%) patients (out of 2,369), oral anticoagulants had been prescribed after the AF diagnosis. In stroke patients, factors like diabetes mellitus and ischemic heart disease were associated with restraint in prescribing oral anticoagulants; age did not influence the decision for or against oral anticoagulants (mean age 72.9 vs. 72.7 years). Conclusion: A recent stroke is a strong preconditioning factor for detecting AF within 5 years after an acute event. The majority of these patients are treated with oral anticoagulants, regardless of their age.
引用
收藏
页码:262 / 269
页数:8
相关论文
共 50 条
  • [21] Secondary Stroke Prevention in Atrial Fibrillation: Indications, Risks, and Benefits
    Peter J. Koudstaal
    Adriana Koudstaal
    Journal of Thrombosis and Thrombolysis, 1999, 7 : 61 - 65
  • [22] Primary and secondary stroke prevention for patients with atrial fibrillation in Latvia
    Jurjans, K.
    Miglane, E.
    Millers, A.
    Priede, Z.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E396 - E397
  • [23] Secondary stroke prevention in atrial fibrillation: a challenge in the clinical practice
    Christian Tanislav
    Sonja Milde
    Sabine Schwartzkopff
    Nicole Sieweke
    Heidrun Helga Krämer
    Martin Juenemann
    Björn Misselwitz
    Manfred Kaps
    BMC Neurology, 14
  • [24] Detection of Atrial Fibrillation After Cryptogenic Stroke
    Richard A. Bernstein
    Current Treatment Options in Cardiovascular Medicine, 2012, 14 (3) : 298 - 304
  • [25] Atrial fibrillation detection after cryptogenic stroke
    Maddalena Alessandra Wu
    Emanuela Scannella
    Internal and Emergency Medicine, 2014, 9 : 887 - 888
  • [26] Atrial fibrillation detection after cryptogenic stroke
    Wu, Maddalena Alessandra
    Scannella, Emanuela
    INTERNAL AND EMERGENCY MEDICINE, 2014, 9 (08) : 887 - 888
  • [27] Detection of atrial fibrillation in patients after stroke
    Siontis, Konstantinos C.
    Noseworthy, Peter A.
    Friedman, Paul A.
    LANCET NEUROLOGY, 2024, 23 (04): : 335 - 336
  • [28] Reassessing the implications of atrial fibrillation detected after stroke
    Kamel, Hooman
    LANCET NEUROLOGY, 2024, 23 (01): : 9 - 11
  • [29] SECONDARY PREVENTION IN NONRHEUMATIC ATRIAL-FIBRILLATION AFTER TRANSIENT ISCHEMIC ATTACK OR MINOR STROKE
    KOUDSTAAL, PJ
    DEHAENE, I
    DHOOGHE, M
    MARCHAU, M
    VANZANDIJCKE, M
    DELWAIDE, C
    DEPRE, A
    LATERRE, EC
    VANBUGGENHOUT, E
    SCHURMANS, J
    DESMET, E
    SWERTS, L
    VANDENABEELE, G
    CARTON, H
    VERDRU, PMA
    INDEKEU, PA
    LAM, D
    VANDENBERGH, V
    VANLANDEGEM, W
    STRAUVEN, T
    BOYSEN, G
    GYRING, J
    PETERSEN, P
    WURTZENNIELSEN, P
    CREPINLEBLOND, T
    MOULIN, T
    AURIACOMBE, S
    ORGOGOZO, JM
    BOULLIAT, J
    GOAS, JY
    MOCQUARD, Y
    BESSON, G
    HOMMEL, M
    ADNETBONTE, C
    JOSIEN, E
    CHEDRU, F
    EVRARD, S
    LEVASSEUR, M
    MAS, JL
    MEYNIARD, O
    ZUBER, M
    AMARENCO, P
    BOUSSER, MG
    ROULLET, E
    PINEL, JF
    MASSARDIER, E
    MIHOUT, B
    CHOLLET, F
    RASCOL, A
    AUTRET, A
    LANCET, 1993, 342 (8882): : 1255 - 1262
  • [30] Atrial fibrillation and stroke prevention
    Hart, RG
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (11): : 1015 - 1016